These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8266741)
1. Effects of long-term treatment of haloperidol on D2 dopamine receptors in various areas of rat brain. Watanabe M; Ohtakeno S; Watanabe H; Mamiya G; Ichinowatari N Yakubutsu Seishin Kodo; 1993 Oct; 13(5):315-9. PubMed ID: 8266741 [TBL] [Abstract][Full Text] [Related]
2. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period. Joyce JN Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025 [TBL] [Abstract][Full Text] [Related]
3. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
4. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography. Videbaek C; Toska K; Friberg L; Holm S; Angelo HR; Knudsen GM J Cereb Blood Flow Metab; 2001 Jan; 21(1):92-7. PubMed ID: 11149673 [TBL] [Abstract][Full Text] [Related]
5. [Characteristics and regulation of 3H-haloperidol binding to rat brain sigma receptors]. Kizu A Yakubutsu Seishin Kodo; 1991 Apr; 11(2):129-39. PubMed ID: 1656649 [TBL] [Abstract][Full Text] [Related]
6. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422 [TBL] [Abstract][Full Text] [Related]
7. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. Schröder U; Schröder H; Augustin W; Sabel BA J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425 [TBL] [Abstract][Full Text] [Related]
9. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat. Hilakivi I; Rinne J; Marjamäki P Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962 [TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. Pehek EA J Pharmacol Exp Ther; 1999 Apr; 289(1):14-23. PubMed ID: 10086982 [TBL] [Abstract][Full Text] [Related]
11. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors. Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320 [TBL] [Abstract][Full Text] [Related]
12. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain. Chong VZ; Skoblenick K; Morin F; Xu Y; Mishra RK Neuroscience; 2006; 138(2):587-99. PubMed ID: 16413126 [TBL] [Abstract][Full Text] [Related]
13. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex. Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646 [TBL] [Abstract][Full Text] [Related]
15. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system. Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972 [TBL] [Abstract][Full Text] [Related]
16. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. Levant B; Grigoriadis DE; DeSouza EB J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136 [TBL] [Abstract][Full Text] [Related]
17. Characterization of D2-dopamine receptor modification in rat striatum after calcium channel blocker treatment. Casellas N; Ferrani A; Cutillas B; Mahy N Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):609-11. PubMed ID: 2150684 [TBL] [Abstract][Full Text] [Related]
18. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Vital MA; Flório JC; Frussa-Filho R; De Lucia R; Tufik S; Palermo-Neto J Life Sci; 1998; 62(13):1161-9. PubMed ID: 9519797 [TBL] [Abstract][Full Text] [Related]
19. The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain. Fishburn CS; David C; Carmon S; Fuchs S FEBS Lett; 1994 Feb; 339(1-2):63-6. PubMed ID: 8313980 [TBL] [Abstract][Full Text] [Related]
20. Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration. Vasar E; Maimets M; Nurk A; Allikmets L Psychopharmacol Bull; 1984; 20(4):691-2. PubMed ID: 6494396 [No Abstract] [Full Text] [Related] [Next] [New Search]